title: Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?
authors.affiliation: IBD Center, Humanitas Research Hospital, Rozzano, Italy Department of Translational Medicine, Università degli Studi di Milano, Milan, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Genua
authors.affiliation: Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Becker
authors.affiliation: IBD Center, Humanitas Research Hospital, Rozzano, Italy Department of Biomedical Sciences, Humanitas University, Milan, Italy stefania.vetrano@humanitasreasearch.it.
authors.forename: Stefania
authors.initials: S
authors.lastname: Vetrano
mesh_terms: D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use; D001343:Autophagy / Q000187:drug effects* / Q000235:genetics / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D057285:Precision Medicine; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha